HEADER TRANSFERASE 10-JUL-18 6H0U TITLE GLYCOGEN SYNTHASE KINASE-3 BETA (GSK3) COMPLEX WITH A COVALENT [1,2, TITLE 2 4]TRIAZOLO[1,5-A][1,3,5]TRIAZINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSK-3 BETA,SERINE/THREONINE-PROTEIN KINASE GSK3B; COMPND 5 EC: 2.7.11.26,2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSK3B; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS PROTEIN KINASE, GSK3BETA-COVALENT INHIBITOR COMPLEX, PARKINSON KEYWDS 2 DISEASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR I.MARCOVICH,N.DEMITRI,R.DE ZORZI,P.STORICI REVDAT 2 17-JAN-24 6H0U 1 REMARK REVDAT 1 15-MAY-19 6H0U 0 JRNL AUTH S.REDENTI,I.MARCOVICH,T.DE VITA,C.PEREZ,R.DE ZORZI, JRNL AUTH 2 N.DEMITRI,D.I.PEREZ,G.BOTTEGONI,P.BISIGNANO,M.BISSARO, JRNL AUTH 3 S.MORO,A.MARTINEZ,P.STORICI,G.SPALLUTO,A.CAVALLI,S.FEDERICO JRNL TITL A TRIAZOLOTRIAZINE-BASED DUAL GSK-3 BETA /CK-1 DELTA LIGAND JRNL TITL 2 AS A POTENTIAL NEUROPROTECTIVE AGENT PRESENTING TWO JRNL TITL 3 DIFFERENT MECHANISMS OF ENZYMATIC INHIBITION. JRNL REF CHEMMEDCHEM V. 14 310 2019 JRNL REFN ESSN 1860-7187 JRNL PMID 30548443 JRNL DOI 10.1002/CMDC.201800778 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0230 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 37543 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1969 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2729 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.3430 REMARK 3 BIN FREE R VALUE SET COUNT : 149 REMARK 3 BIN FREE R VALUE : 0.4010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5580 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 266 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.10000 REMARK 3 B22 (A**2) : 1.14000 REMARK 3 B33 (A**2) : -0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.295 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.224 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.187 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.157 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5793 ; 0.009 ; 0.014 REMARK 3 BOND LENGTHS OTHERS (A): 5252 ; 0.002 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7872 ; 1.386 ; 1.681 REMARK 3 BOND ANGLES OTHERS (DEGREES): 12339 ; 0.994 ; 1.642 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 690 ; 6.522 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 302 ;33.163 ;21.060 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 964 ;15.522 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 46 ;20.277 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 753 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6384 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1044 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2778 ; 2.807 ; 3.692 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2777 ; 2.807 ; 3.691 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3462 ; 4.549 ; 5.534 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3463 ; 4.548 ; 5.536 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3015 ; 3.157 ; 4.105 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 3015 ; 3.157 ; 4.105 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4411 ; 5.098 ; 5.969 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 6441 ; 7.996 ;42.318 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 6419 ; 7.993 ;42.315 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 36 A 383 5 REMARK 3 1 B 36 B 383 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 2043 ; 0.27 ; 0.50 REMARK 3 LOOSE POSITIONAL 1 A (A): 3387 ; 0.57 ; 5.00 REMARK 3 MEDIUM THERMAL 1 B (A**2): 2043 ; 5.84 ; 2.00 REMARK 3 LOOSE THERMAL 1 B (A**2): 3387 ; 6.32 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6H0U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-JUL-18. REMARK 100 THE DEPOSITION ID IS D_1200010866. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JAN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ELETTRA REMARK 200 BEAMLINE : 5.2R REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39567 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 47.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1Q5K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: GSK3BETA(35-386) ALIQUOTS WERE REMARK 280 CONCENTRATED TO 4.4 MG/ML AND USED FOR CRYSTALLIZATION TRIALS. REMARK 280 GSK3B-INHIBITOR CO-CRYSTALS WERE GROWN USING THE SITTING DROP REMARK 280 VAPOR DIFFUSION TECHNIQUE IN 0.2M DL-MALIC ACID PH 7.0, 20% PEG REMARK 280 3350 AS RESERVOIR SOLUTION. THE PROTEIN WAS PREVIOUSLY INCUBATED REMARK 280 WITH 3X MOLAR EXCESS OF COMPOUND FOR 3H AT 4C. CRYSTALLIZATION REMARK 280 DROPS WERE PREPARED FROM 0.5UL OF PROTEIN SOLUTION AND 0.5UL OF REMARK 280 RESERVOIR, AND INCUBATED FOR 10 DAYS AT 20C. CRYSTALS WERE REMARK 280 CRYOPROTECTED IN 30% GLYCEROL AND FROZEN IN LIQUID NITROGEN REMARK 280 PRIOR TO DATA COLLECTION., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.40150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.28950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.27100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.28950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.40150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.27100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ARG A 4 REMARK 465 PRO A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 THR A 8 REMARK 465 SER A 9 REMARK 465 PHE A 10 REMARK 465 ALA A 11 REMARK 465 GLU A 12 REMARK 465 SER A 13 REMARK 465 CYS A 14 REMARK 465 LYS A 15 REMARK 465 PRO A 16 REMARK 465 VAL A 17 REMARK 465 GLN A 18 REMARK 465 GLN A 19 REMARK 465 PRO A 20 REMARK 465 SER A 21 REMARK 465 ALA A 22 REMARK 465 PHE A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 MET A 26 REMARK 465 LYS A 27 REMARK 465 VAL A 28 REMARK 465 SER A 29 REMARK 465 ARG A 30 REMARK 465 ASP A 31 REMARK 465 LYS A 32 REMARK 465 ASP A 33 REMARK 465 GLY A 34 REMARK 465 SER A 35 REMARK 465 ILE A 384 REMARK 465 GLN A 385 REMARK 465 ALA A 386 REMARK 465 ALA A 387 REMARK 465 ALA A 388 REMARK 465 SER A 389 REMARK 465 THR A 390 REMARK 465 PRO A 391 REMARK 465 THR A 392 REMARK 465 ASN A 393 REMARK 465 ALA A 394 REMARK 465 THR A 395 REMARK 465 ALA A 396 REMARK 465 ALA A 397 REMARK 465 SER A 398 REMARK 465 ASP A 399 REMARK 465 ALA A 400 REMARK 465 ASN A 401 REMARK 465 THR A 402 REMARK 465 GLY A 403 REMARK 465 ASP A 404 REMARK 465 ARG A 405 REMARK 465 GLY A 406 REMARK 465 GLN A 407 REMARK 465 THR A 408 REMARK 465 ASN A 409 REMARK 465 ASN A 410 REMARK 465 ALA A 411 REMARK 465 ALA A 412 REMARK 465 SER A 413 REMARK 465 ALA A 414 REMARK 465 SER A 415 REMARK 465 ALA A 416 REMARK 465 SER A 417 REMARK 465 ASN A 418 REMARK 465 SER A 419 REMARK 465 THR A 420 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ARG B 4 REMARK 465 PRO B 5 REMARK 465 ARG B 6 REMARK 465 THR B 7 REMARK 465 THR B 8 REMARK 465 SER B 9 REMARK 465 PHE B 10 REMARK 465 ALA B 11 REMARK 465 GLU B 12 REMARK 465 SER B 13 REMARK 465 CYS B 14 REMARK 465 LYS B 15 REMARK 465 PRO B 16 REMARK 465 VAL B 17 REMARK 465 GLN B 18 REMARK 465 GLN B 19 REMARK 465 PRO B 20 REMARK 465 SER B 21 REMARK 465 ALA B 22 REMARK 465 PHE B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 MET B 26 REMARK 465 LYS B 27 REMARK 465 VAL B 28 REMARK 465 SER B 29 REMARK 465 ARG B 30 REMARK 465 ASP B 31 REMARK 465 LYS B 32 REMARK 465 ASP B 33 REMARK 465 GLY B 34 REMARK 465 SER B 35 REMARK 465 ILE B 384 REMARK 465 GLN B 385 REMARK 465 ALA B 386 REMARK 465 ALA B 387 REMARK 465 ALA B 388 REMARK 465 SER B 389 REMARK 465 THR B 390 REMARK 465 PRO B 391 REMARK 465 THR B 392 REMARK 465 ASN B 393 REMARK 465 ALA B 394 REMARK 465 THR B 395 REMARK 465 ALA B 396 REMARK 465 ALA B 397 REMARK 465 SER B 398 REMARK 465 ASP B 399 REMARK 465 ALA B 400 REMARK 465 ASN B 401 REMARK 465 THR B 402 REMARK 465 GLY B 403 REMARK 465 ASP B 404 REMARK 465 ARG B 405 REMARK 465 GLY B 406 REMARK 465 GLN B 407 REMARK 465 THR B 408 REMARK 465 ASN B 409 REMARK 465 ASN B 410 REMARK 465 ALA B 411 REMARK 465 ALA B 412 REMARK 465 SER B 413 REMARK 465 ALA B 414 REMARK 465 SER B 415 REMARK 465 ALA B 416 REMARK 465 SER B 417 REMARK 465 ASN B 418 REMARK 465 SER B 419 REMARK 465 THR B 420 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 705 O HOH A 715 1.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LEU A 198 C CYS A 199 N 0.199 REMARK 500 CYS A 199 C ASP A 200 N 0.219 REMARK 500 LEU B 198 C CYS B 199 N 0.165 REMARK 500 CYS B 199 C ASP B 200 N 0.234 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 198 O - C - N ANGL. DEV. = -10.5 DEGREES REMARK 500 CYS A 199 CB - CA - C ANGL. DEV. = 8.5 DEGREES REMARK 500 LEU B 198 O - C - N ANGL. DEV. = -15.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 49 38.01 -76.45 REMARK 500 ASP A 181 51.11 -153.47 REMARK 500 ASP A 200 94.18 62.01 REMARK 500 CYS A 218 143.45 84.06 REMARK 500 ARG A 220 -76.63 -13.27 REMARK 500 PRO A 357 -177.62 -65.16 REMARK 500 ASN A 370 78.00 -162.31 REMARK 500 ALA A 382 19.11 -143.63 REMARK 500 ASP B 49 57.90 -67.65 REMARK 500 ARG B 92 -71.91 -56.90 REMARK 500 GLU B 121 -75.66 -62.80 REMARK 500 LEU B 153 130.79 -39.41 REMARK 500 ASP B 181 48.95 -150.04 REMARK 500 ASP B 200 93.29 68.36 REMARK 500 CYS B 218 138.70 80.61 REMARK 500 TYR B 221 -29.52 101.55 REMARK 500 ARG B 308 -17.61 80.74 REMARK 500 ASN B 370 70.00 -167.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 113 0.13 SIDE CHAIN REMARK 500 ARG A 144 0.09 SIDE CHAIN REMARK 500 ARG A 180 0.23 SIDE CHAIN REMARK 500 ARG A 278 0.09 SIDE CHAIN REMARK 500 ARG A 328 0.10 SIDE CHAIN REMARK 500 ARG A 344 0.23 SIDE CHAIN REMARK 500 ARG B 144 0.09 SIDE CHAIN REMARK 500 ARG B 209 0.09 SIDE CHAIN REMARK 500 ARG B 220 0.12 SIDE CHAIN REMARK 500 ARG B 306 0.11 SIDE CHAIN REMARK 500 ARG B 344 0.09 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LEU A 198 17.87 REMARK 500 CYS A 199 -16.69 REMARK 500 LEU B 198 22.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 723 DISTANCE = 6.53 ANGSTROMS REMARK 525 HOH B 724 DISTANCE = 6.92 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FKB A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MLI A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA B 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide FKB B 501 and CYS B REMARK 800 199 DBREF 6H0U A 1 420 UNP P49841 GSK3B_HUMAN 1 420 DBREF 6H0U B 1 420 UNP P49841 GSK3B_HUMAN 1 420 SEQRES 1 A 420 MET SER GLY ARG PRO ARG THR THR SER PHE ALA GLU SER SEQRES 2 A 420 CYS LYS PRO VAL GLN GLN PRO SER ALA PHE GLY SER MET SEQRES 3 A 420 LYS VAL SER ARG ASP LYS ASP GLY SER LYS VAL THR THR SEQRES 4 A 420 VAL VAL ALA THR PRO GLY GLN GLY PRO ASP ARG PRO GLN SEQRES 5 A 420 GLU VAL SER TYR THR ASP THR LYS VAL ILE GLY ASN GLY SEQRES 6 A 420 SER PHE GLY VAL VAL TYR GLN ALA LYS LEU CYS ASP SER SEQRES 7 A 420 GLY GLU LEU VAL ALA ILE LYS LYS VAL LEU GLN ASP LYS SEQRES 8 A 420 ARG PHE LYS ASN ARG GLU LEU GLN ILE MET ARG LYS LEU SEQRES 9 A 420 ASP HIS CYS ASN ILE VAL ARG LEU ARG TYR PHE PHE TYR SEQRES 10 A 420 SER SER GLY GLU LYS LYS ASP GLU VAL TYR LEU ASN LEU SEQRES 11 A 420 VAL LEU ASP TYR VAL PRO GLU THR VAL TYR ARG VAL ALA SEQRES 12 A 420 ARG HIS TYR SER ARG ALA LYS GLN THR LEU PRO VAL ILE SEQRES 13 A 420 TYR VAL LYS LEU TYR MET TYR GLN LEU PHE ARG SER LEU SEQRES 14 A 420 ALA TYR ILE HIS SER PHE GLY ILE CYS HIS ARG ASP ILE SEQRES 15 A 420 LYS PRO GLN ASN LEU LEU LEU ASP PRO ASP THR ALA VAL SEQRES 16 A 420 LEU LYS LEU CYS ASP PHE GLY SER ALA LYS GLN LEU VAL SEQRES 17 A 420 ARG GLY GLU PRO ASN VAL SER TYR ILE CYS SER ARG TYR SEQRES 18 A 420 TYR ARG ALA PRO GLU LEU ILE PHE GLY ALA THR ASP TYR SEQRES 19 A 420 THR SER SER ILE ASP VAL TRP SER ALA GLY CYS VAL LEU SEQRES 20 A 420 ALA GLU LEU LEU LEU GLY GLN PRO ILE PHE PRO GLY ASP SEQRES 21 A 420 SER GLY VAL ASP GLN LEU VAL GLU ILE ILE LYS VAL LEU SEQRES 22 A 420 GLY THR PRO THR ARG GLU GLN ILE ARG GLU MET ASN PRO SEQRES 23 A 420 ASN TYR THR GLU PHE LYS PHE PRO GLN ILE LYS ALA HIS SEQRES 24 A 420 PRO TRP THR LYS VAL PHE ARG PRO ARG THR PRO PRO GLU SEQRES 25 A 420 ALA ILE ALA LEU CYS SER ARG LEU LEU GLU TYR THR PRO SEQRES 26 A 420 THR ALA ARG LEU THR PRO LEU GLU ALA CYS ALA HIS SER SEQRES 27 A 420 PHE PHE ASP GLU LEU ARG ASP PRO ASN VAL LYS LEU PRO SEQRES 28 A 420 ASN GLY ARG ASP THR PRO ALA LEU PHE ASN PHE THR THR SEQRES 29 A 420 GLN GLU LEU SER SER ASN PRO PRO LEU ALA THR ILE LEU SEQRES 30 A 420 ILE PRO PRO HIS ALA ARG ILE GLN ALA ALA ALA SER THR SEQRES 31 A 420 PRO THR ASN ALA THR ALA ALA SER ASP ALA ASN THR GLY SEQRES 32 A 420 ASP ARG GLY GLN THR ASN ASN ALA ALA SER ALA SER ALA SEQRES 33 A 420 SER ASN SER THR SEQRES 1 B 420 MET SER GLY ARG PRO ARG THR THR SER PHE ALA GLU SER SEQRES 2 B 420 CYS LYS PRO VAL GLN GLN PRO SER ALA PHE GLY SER MET SEQRES 3 B 420 LYS VAL SER ARG ASP LYS ASP GLY SER LYS VAL THR THR SEQRES 4 B 420 VAL VAL ALA THR PRO GLY GLN GLY PRO ASP ARG PRO GLN SEQRES 5 B 420 GLU VAL SER TYR THR ASP THR LYS VAL ILE GLY ASN GLY SEQRES 6 B 420 SER PHE GLY VAL VAL TYR GLN ALA LYS LEU CYS ASP SER SEQRES 7 B 420 GLY GLU LEU VAL ALA ILE LYS LYS VAL LEU GLN ASP LYS SEQRES 8 B 420 ARG PHE LYS ASN ARG GLU LEU GLN ILE MET ARG LYS LEU SEQRES 9 B 420 ASP HIS CYS ASN ILE VAL ARG LEU ARG TYR PHE PHE TYR SEQRES 10 B 420 SER SER GLY GLU LYS LYS ASP GLU VAL TYR LEU ASN LEU SEQRES 11 B 420 VAL LEU ASP TYR VAL PRO GLU THR VAL TYR ARG VAL ALA SEQRES 12 B 420 ARG HIS TYR SER ARG ALA LYS GLN THR LEU PRO VAL ILE SEQRES 13 B 420 TYR VAL LYS LEU TYR MET TYR GLN LEU PHE ARG SER LEU SEQRES 14 B 420 ALA TYR ILE HIS SER PHE GLY ILE CYS HIS ARG ASP ILE SEQRES 15 B 420 LYS PRO GLN ASN LEU LEU LEU ASP PRO ASP THR ALA VAL SEQRES 16 B 420 LEU LYS LEU CYS ASP PHE GLY SER ALA LYS GLN LEU VAL SEQRES 17 B 420 ARG GLY GLU PRO ASN VAL SER TYR ILE CYS SER ARG TYR SEQRES 18 B 420 TYR ARG ALA PRO GLU LEU ILE PHE GLY ALA THR ASP TYR SEQRES 19 B 420 THR SER SER ILE ASP VAL TRP SER ALA GLY CYS VAL LEU SEQRES 20 B 420 ALA GLU LEU LEU LEU GLY GLN PRO ILE PHE PRO GLY ASP SEQRES 21 B 420 SER GLY VAL ASP GLN LEU VAL GLU ILE ILE LYS VAL LEU SEQRES 22 B 420 GLY THR PRO THR ARG GLU GLN ILE ARG GLU MET ASN PRO SEQRES 23 B 420 ASN TYR THR GLU PHE LYS PHE PRO GLN ILE LYS ALA HIS SEQRES 24 B 420 PRO TRP THR LYS VAL PHE ARG PRO ARG THR PRO PRO GLU SEQRES 25 B 420 ALA ILE ALA LEU CYS SER ARG LEU LEU GLU TYR THR PRO SEQRES 26 B 420 THR ALA ARG LEU THR PRO LEU GLU ALA CYS ALA HIS SER SEQRES 27 B 420 PHE PHE ASP GLU LEU ARG ASP PRO ASN VAL LYS LEU PRO SEQRES 28 B 420 ASN GLY ARG ASP THR PRO ALA LEU PHE ASN PHE THR THR SEQRES 29 B 420 GLN GLU LEU SER SER ASN PRO PRO LEU ALA THR ILE LEU SEQRES 30 B 420 ILE PRO PRO HIS ALA ARG ILE GLN ALA ALA ALA SER THR SEQRES 31 B 420 PRO THR ASN ALA THR ALA ALA SER ASP ALA ASN THR GLY SEQRES 32 B 420 ASP ARG GLY GLN THR ASN ASN ALA ALA SER ALA SER ALA SEQRES 33 B 420 SER ASN SER THR HET FKB A 501 24 HET MLI A 502 7 HET GOL A 503 6 HET FKB B 501 24 HET GOL B 502 6 HET GOL B 503 6 HET CL B 504 1 HET CL B 505 1 HET NA B 506 1 HETNAM FKB (2~{R})-3-[7-AZANYL-5-(CYCLOHEXYLAMINO)-[1,2, HETNAM 2 FKB 4]TRIAZOLO[1,5-A][1,3,5]TRIAZIN-2-YL]-2-CYANO- HETNAM 3 FKB PROPANAMIDE HETNAM MLI MALONATE ION HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETNAM NA SODIUM ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 FKB 2(C14 H19 N9 O) FORMUL 4 MLI C3 H2 O4 2- FORMUL 5 GOL 3(C3 H8 O3) FORMUL 9 CL 2(CL 1-) FORMUL 11 NA NA 1+ FORMUL 12 HOH *266(H2 O) HELIX 1 AA1 ASN A 95 ARG A 102 1 8 HELIX 2 AA2 VAL A 139 ALA A 149 1 11 HELIX 3 AA3 PRO A 154 PHE A 175 1 22 HELIX 4 AA4 LYS A 183 GLN A 185 5 3 HELIX 5 AA5 SER A 219 ARG A 223 5 5 HELIX 6 AA6 ALA A 224 PHE A 229 1 6 HELIX 7 AA7 SER A 236 GLY A 253 1 18 HELIX 8 AA8 SER A 261 GLY A 274 1 14 HELIX 9 AA9 THR A 277 ASN A 285 1 9 HELIX 10 AB1 PRO A 286 THR A 289 5 4 HELIX 11 AB2 PRO A 300 PHE A 305 1 6 HELIX 12 AB3 PRO A 310 LEU A 321 1 12 HELIX 13 AB4 THR A 324 ARG A 328 5 5 HELIX 14 AB5 THR A 330 ALA A 336 1 7 HELIX 15 AB6 HIS A 337 PHE A 339 5 3 HELIX 16 AB7 PHE A 340 ASP A 345 1 6 HELIX 17 AB8 THR A 363 SER A 368 1 6 HELIX 18 AB9 ASN A 370 PRO A 372 5 3 HELIX 19 AC1 LEU A 373 ILE A 378 1 6 HELIX 20 AC2 PRO A 379 ARG A 383 5 5 HELIX 21 AC3 ASN B 95 LEU B 104 1 10 HELIX 22 AC4 VAL B 139 ALA B 149 1 11 HELIX 23 AC5 PRO B 154 PHE B 175 1 22 HELIX 24 AC6 LYS B 183 GLN B 185 5 3 HELIX 25 AC7 ALA B 224 PHE B 229 1 6 HELIX 26 AC8 SER B 236 GLY B 253 1 18 HELIX 27 AC9 SER B 261 GLY B 274 1 14 HELIX 28 AD1 THR B 277 ASN B 285 1 9 HELIX 29 AD2 PRO B 286 THR B 289 5 4 HELIX 30 AD3 PRO B 300 VAL B 304 5 5 HELIX 31 AD4 PRO B 310 LEU B 321 1 12 HELIX 32 AD5 THR B 324 ARG B 328 5 5 HELIX 33 AD6 THR B 330 ALA B 336 1 7 HELIX 34 AD7 HIS B 337 ASP B 345 5 9 HELIX 35 AD8 THR B 363 SER B 368 1 6 HELIX 36 AD9 ASN B 370 PRO B 372 5 3 HELIX 37 AE1 LEU B 373 ILE B 378 1 6 HELIX 38 AE2 PRO B 379 ARG B 383 5 5 SHEET 1 AA1 7 VAL A 37 PRO A 44 0 SHEET 2 AA1 7 GLN A 52 GLY A 63 -1 O TYR A 56 N THR A 38 SHEET 3 AA1 7 GLY A 68 LEU A 75 -1 O GLN A 72 N LYS A 60 SHEET 4 AA1 7 LEU A 81 LEU A 88 -1 O ILE A 84 N TYR A 71 SHEET 5 AA1 7 TYR A 127 ASP A 133 -1 O LEU A 132 N ALA A 83 SHEET 6 AA1 7 LEU A 112 SER A 118 -1 N SER A 118 O TYR A 127 SHEET 7 AA1 7 VAL A 37 PRO A 44 -1 N THR A 43 O PHE A 115 SHEET 1 AA2 3 GLU A 137 THR A 138 0 SHEET 2 AA2 3 LEU A 187 ASP A 190 -1 O LEU A 189 N GLU A 137 SHEET 3 AA2 3 VAL A 195 LEU A 198 -1 O LYS A 197 N LEU A 188 SHEET 1 AA3 2 ILE A 177 CYS A 178 0 SHEET 2 AA3 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 SHEET 1 AA4 7 THR B 38 PRO B 44 0 SHEET 2 AA4 7 GLN B 52 ASN B 64 -1 O TYR B 56 N THR B 38 SHEET 3 AA4 7 GLY B 68 LEU B 75 -1 O GLN B 72 N LYS B 60 SHEET 4 AA4 7 LEU B 81 LEU B 88 -1 O ILE B 84 N TYR B 71 SHEET 5 AA4 7 TYR B 127 ASP B 133 -1 O LEU B 128 N VAL B 87 SHEET 6 AA4 7 LEU B 112 SER B 118 -1 N TYR B 114 O VAL B 131 SHEET 7 AA4 7 THR B 38 PRO B 44 -1 N THR B 43 O PHE B 115 SHEET 1 AA5 3 GLU B 137 THR B 138 0 SHEET 2 AA5 3 LEU B 187 LEU B 189 -1 O LEU B 189 N GLU B 137 SHEET 3 AA5 3 LEU B 196 LEU B 198 -1 O LYS B 197 N LEU B 188 SHEET 1 AA6 2 ILE B 177 CYS B 178 0 SHEET 2 AA6 2 LYS B 205 GLN B 206 -1 O LYS B 205 N CYS B 178 LINK SG CYS A 199 C2 FKB A 501 1555 1555 1.86 LINK SG CYS B 199 C2 FKB B 501 1555 1555 1.89 SITE 1 AC1 12 VAL A 70 ALA A 83 LYS A 85 VAL A 110 SITE 2 AC1 12 LEU A 132 ASP A 133 TYR A 134 VAL A 135 SITE 3 AC1 12 ARG A 141 LEU A 188 CYS A 199 ASP A 200 SITE 1 AC2 7 ARG A 96 ARG A 180 LYS A 205 ASN A 213 SITE 2 AC2 7 VAL A 214 LYS B 292 HOH B 653 SITE 1 AC3 5 TYR A 56 TYR A 71 LYS A 86 SER A 118 SITE 2 AC3 5 ASN A 129 SITE 1 AC4 7 PHE A 291 LYS A 292 ARG B 96 ARG B 180 SITE 2 AC4 7 LYS B 205 VAL B 214 GOL B 503 SITE 1 AC5 3 GLY B 202 TYR B 216 GOL B 502 SITE 1 AC6 1 TYR B 161 SITE 1 AC7 1 GLU B 283 SITE 1 AC8 17 VAL B 70 ALA B 83 LYS B 85 ASP B 133 SITE 2 AC8 17 TYR B 134 VAL B 135 PRO B 136 GLU B 137 SITE 3 AC8 17 ARG B 141 HIS B 179 ASN B 186 LEU B 188 SITE 4 AC8 17 LYS B 197 LEU B 198 ASP B 200 HOH B 682 SITE 5 AC8 17 HOH B 683 CRYST1 86.803 94.542 106.579 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011520 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010577 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009383 0.00000 MTRIX1 1 1.000000 0.000000 0.000000 0.00000 1 MTRIX2 1 0.000000 1.000000 0.000000 0.00000 1 MTRIX3 1 0.000000 0.000000 1.000000 0.00000 1 MTRIX1 2 -0.099045 0.599151 0.794486 36.85856 1 MTRIX2 2 0.639686 -0.573242 0.512049 -68.10525 1 MTRIX3 2 0.762228 0.558938 -0.326492 11.53673 1